Expert Review of Pharmacoeconomics and Outcomes Research

SJR Rank #11,654H-index: 69SJR: 0.511Best quartile: Q3
Journal website: aims, scope and author guidelines
Publisher

Taylor and Francis Ltd.

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.150.30.450.6

Subject Categories

  • Health PolicyQ3
  • Medicine (miscellaneous)Q3
  • Pharmacology (medical)Q3

Areas: Medicine

Most published research topics

Health Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and PolicyEconomic and Financial Impacts of CancerHealthcare Policy and ManagementGlobal Health Care IssuesMedication Adherence and ComplianceHealthcare cost, quality, practicesEconomic and Environmental ValuationBiosimilars and Bioanalytical MethodsCancer survivorship and care

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs090180270360

Documents per Year

2022202504080120160

Detailed Information

ISSN

1473-7167, 1744-8379

SJR Best Quartile

Q3

Region

Western Europe

Citations per Document (2 years)

2.19

References per Document

45.32

Coverage

2001-2026

Scope

Expert Review of Pharmacoeconomics & Outcomes Research (ISSN 1473-7167) provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review. The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections: Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results Article Highlights – an executive summary of the author’s most critical points.

Metrics from SCImago Journal Rank 2025. View on SCImago